{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Surgical Ventricular Reconstruction in Ischemic Heart Failure"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In this randomised controlled trial, 1000 patients with ischemic heart failure were randomised"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive either CABG alone or CABG plus SVR"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was survival, measured at 4 months postoperatively"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable due to the nature of the interventions"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "1000 patients with ischemic heart failure were randomised"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "The analysis was conducted per-protocol"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "SVR improved survival compared to CABG alone when the postoperative end-systolic volume index was \u226470 mL/m\u00b2"
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]"
      }
    },
    "total_score": 13,
    "max_score": 25
  },
  "model": "gpt-4o"
}